The TELO-SCOPE study: Attenuating Telomere Attrition with Danazol. Is there Scope to Dramatically Improve Health Outcomes for Adults and Children with Pulmonary Fibrosis

Chambers, Daniel (Primary Chief Investigator (PCI))
Corte, Tamera Jo (Chief Investigator (CI))
Jaffe, Adam D. (Chief Investigator (CI))
Glaspole, Ian (Chief Investigator (CI))
Hopkins, Peter Mark Anthony (Chief Investigator (CI))
Goh, Nicole Soo Leng (Chief Investigator (CI))
Grainge, Christopher (Chief Investigator (CI))
Macintosh, John (Chief Investigator (CI))
Selvadurai, Hiran (Chief Investigator (CI))

School of Translational Medicine

Project: Research

Status	Finished
Effective start/end date	1/06/20 → 31/05/25

1 Article

TELO-SCOPE study: A randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis
MacKintosh, J. A., Pietsch, M., Lutzky, V., Enever, D., Bancroft, S., Apte, S. H., Tan, M., Yerkovich, S. T., Dickinson, J. L., Pickett, H. A., Selvadurai, H., Grainge, C., Goh, N. S., Hopkins, P., Glaspole, I., Reynolds, P. N., Wrobel, J., Jaffe, A., Corte, T. J. & Chambers, D. C., 2 Dec 2021, In: BMJ Open Respiratory Research. 8, 1, 8 p., e001127.
Research output: Contribution to journal › Article › Other › peer-review

Open Access

17 Citations (Scopus)